Product

MGI Announces European Launch of New MGISP-Smart 8 Automated Sample Preparation System and Empowerment Program at MEDICA to Further Access to Genomics

Retrieved on: 
Monday, November 14, 2022
Health, Technology, Precision medicine, General manager, Software, Acceleration, Product marketing, Genetic testing, Belgrade Fair – Hall 1, YouTube, Research, Reproductive health, Certification, Product, Trioza alacris, MEDICA, Agriculture, MGI, IVDR, Genomics, Fine chemical

Representatives from MGI IMABOT will also be present to showcase the robotic ultrasound system MGIUS-R3.

Key Points: 
  • Representatives from MGI IMABOT will also be present to showcase the robotic ultrasound system MGIUS-R3.
  • MGI is a leading producer of clinical high-throughput gene sequencers***, and its multi-omics platforms include genetic sequencing***, medical imaging, and laboratory automation.
  • Unless otherwise informed, StandardMPS sequencing reagents, and sequencers for use with such reagents are not available in Hong Kong.
  • No purchase orders for StandardMPS products will be accepted in the USA until after January 1, 2023.

CRISPR and CAS Genes Global Market Report 2022: Technological Advancements in CRISPR System Fueling Growth - ResearchAndMarkets.com

Retrieved on: 
Friday, November 11, 2022
Health, Genetics, Disease, Product-service system, Product, Investment, Region, Gene, USD, Biomedical Research, CAGR, CRISPR, Application, Goal, Biotechnology, Cros, Therapy, COVID-19, Growth, CAS, Medical device, Antibiotics, Fine chemical

The "CRISPR and CAS Genes Market Analysis by Product & Service, by Application by End user, and by Region - Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "CRISPR and CAS Genes Market Analysis by Product & Service, by Application by End user, and by Region - Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.
  • The CRISPR and CAS genes market size is estimated to be USD 1095 million in 2021 and is expected to witness a CAGR of 26.82% during the forecast period 2022-2029.
  • The development of CRISPR-based diagnostic assays to overcome the timeline and sample collection issues for COVID-19 screening and technological advancements in CRISPR are factors contributing to the market growth.
  • In 2021, North America region accounted for the highest revenue in the CRISPR and CAS genes market and is expected to maintain its dominance during the forecast period.

EQS-News: va-Q-tec continues on its growth track in the first nine months of 2022

Retrieved on: 
Friday, November 11, 2022
Health care, Service, ISIN, Technology, Financial Oversight and Management Board for Puerto Rico, Sale, Depreciation, Uponor, Product, Solution, Supervisory board, EBITDA, Paulo, Adjustment, System, Growth, EUR, Medication, Income, Fine chemical, Risk management, Group, Euro

Overall, the revenue trend in the first nine months of 2022 remained very encouraging despite the challenging macroeconomic environment.

Key Points: 
  • Overall, the revenue trend in the first nine months of 2022 remained very encouraging despite the challenging macroeconomic environment.
  • Revenues posted strong year-on-year growth of 12% to EUR82.1million in the first nine months of 2022 (9M 2021: EUR73.4million).
  • The coronavirus business accounted for 16% of revenues in 9M 2022, compared with 18% in 9M 2021.
  • Overall, the non-Covid-related TempChain business thereby grew by +20% in 9M 2022 and the TempChain business as a whole grew by +15%.

Oyster Point Pharma Reports Third Quarter 2022 Financial Results and Recent Business Highlights

Retrieved on: 
Thursday, November 10, 2022
IND, Homeostasis, Safety, Research, Risk, First, Development, Ophthalmology, Public relations, Stinger, Tender, Company, Trigeminal nerve, Program, Nach, Letter, Security (finance), Administration, Industry, Marketing, Rest, Throat irritation, Nose, Prescription, SEC, Scratching, U.S. Securities and Exchange Commission, AAV, Science, AKC, User experience, Patient, Money transmitter, Acquisition, Schedule, Tender offer, COVID-19, IgG4-related ophthalmic disease, Protein, Parasympathetic nervous system, Nasdaq, Dry eye syndrome, OP, Eye, Antibody, Product, Nasal spray, Sneeze, Growth, NGF, FDA, GLOBE, Lipid, Cough, ETF, Failure, VKC, DAO, Vernal keratoconjunctivitis, MMS, INT, Signs and symptoms, NK, CVR, Histamine, Duane syndrome, Pharmaceutical industry, Health insurance, Fine chemical, Parent, Income, Varenicline, Viatris

During the third quarter of 2022, the Company also disclosed an additional target and further indications for its ETF gene therapy program.

Key Points: 
  • During the third quarter of 2022, the Company also disclosed an additional target and further indications for its ETF gene therapy program.
  • Cash Position: As of September30, 2022, cash and cash equivalents was $68.8 million, compared to $104.9 million as of June 30, 2022.
  • Oyster Point Pharma is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ophthalmic diseases.
  • The tender offer for the outstanding common stock of Oyster Point Pharma Inc. (OP) has not yet been commenced.

DBV Technologies to Highlight New Clinical Data at ACAAI 2022

Retrieved on: 
Wednesday, November 9, 2022
Aurora, ACAAI, 2021 Essex County Council election, Convention, Reaction, Children's Hospital Colorado, Nasdaq, Food, Knowledge, Immunotherapy, EST, Risk, ISIN, Epidemiology, Regulation of tobacco by the U.S. Food and Drug Administration, Allergy, Food allergy, SEC, Safety, U.S. Securities and Exchange Commission, Company, Ticker, Product, European Medicines Agency, MBA, Skin, Peanut allergy, Porta Palazzo Exhibition Hall, Policy by press release, Immune system, Patient, Evolution, Treatment, DBV Technologies, AMF, American College, Pharmaceutical industry, DBV, Euronext, Euronext Paris

DBV will also host a booth in the ACAAI Exhibit Hall from Friday, November 11, through Sunday, November 13.

Key Points: 
  • DBV will also host a booth in the ACAAI Exhibit Hall from Friday, November 11, through Sunday, November 13.
  • DBV is the sole sponsor, via an independent educational grant, of the International Food Allergy Symposium, a full-day symposium that kicks off ACAAI.
  • The additional data being presented at this year's ACAAI meeting highlight the potential for Viaskin Peanut as a treatment option for this young and vulnerable patient population if approved, said Dr. Pharis Mohideen, Chief Medical Officer of DBV Technologies.
  • Other than as required by applicable law, DBV Technologies undertakes no obligation to update or revise the information contained in this Press Release.

Global Point Of Care Diagnostics Market 2022: Developments Including AI Integration Drive Sector Forward - ResearchAndMarkets.com

Retrieved on: 
Thursday, November 10, 2022
Health Technology, Health, Medical Supplies, Medical Devices, Cloud, Drug, Hospital, Texas Homecare, Respiratory syncytial virus, USD, Time-invariant system, Prevalence, Postprandial glucose test, Fasting, United Nations, HBV, End, HIV/AIDS, Diabetes, HSV, Conditional sentence, Coagulation testing, RSV, Population, Microfluidics, HPV, Diagnosis, Artificial intelligence, HCV, CDC, CAGR, Multidrug-resistant tuberculosis, Urinary tract infection, Infection, Time, Virus, IDF, Cancer, DOA, Rheumatism, Product, First Nations in Ontario, Patient, Analysis, Death, Respiratory tract infection, MRSA, TB, HIV, Degenerative disease, COVID-19, POC, Medical device, Pharmaceutical industry, Vaccine, Pneumonia

The "Global Point Of Care Diagnostics Market, By Product type, By End users, By Platform- Forecast and Analysis 2022-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Point Of Care Diagnostics Market, By Product type, By End users, By Platform- Forecast and Analysis 2022-2028" report has been added to ResearchAndMarkets.com's offering.
  • The increase in the prevalence of chronic and infectious diseases in developing economies is one of the point of care diagnostics market growth factor.
  • Global Point of Care Diagnostics Market is segmented based on product type, end users, and platform.
  • Based on end users, global point of care diagnostics market is further segmented into clinics, hospitals, homecare, assisted living healthcare facilities, laboratory.

Breezeline Launches Cloud-Based “Hosted Voice Essential” Phone Service Designed for Small Businesses

Retrieved on: 
Thursday, November 10, 2022
Technology, Mobile, Wireless, Telecommunications, Professional Services, Small Business, Software, Networks, Internet, VoIP, CCA, Data-rate units, Human voice, Essential, Internet, Product, Android, Maintenance, Hosting, TSX, IOS, Cogeco, Mobile phone

Breezeline, the nations eighth-largest cable operator, has launched Hosted Voice Essential, a new cloud-based phone service tailored specifically for smaller businesses.

Key Points: 
  • Breezeline, the nations eighth-largest cable operator, has launched Hosted Voice Essential, a new cloud-based phone service tailored specifically for smaller businesses.
  • Breezeline first introduced Hosted Voice in 2016 and it quickly became a popular option for enterprise and larger businesses.
  • Breezeline developed the new Hosted Voice Essential service in response to growing interest among smaller businesses for a cloud-based voice solution.
  • Scaled for 1-4 users, the Essential service includes the following features:
    Mobility features including voicemail to email, mobile extensions for iOS and Android
    The Breezeline Hosted Voice Essential service also includes critical security, operations and maintenance expertiseincluding 24x7 monitoring and supportthat small businesses need, which is often cost prohibitive with on-premise phone systems.

URC and ZeeVee Launch Compatible Audio-Video Control System

Retrieved on: 
Thursday, November 10, 2022
Hospitality, Human, Total Control, Amazon, Partnership, Google Nest (smart speakers), AV, Education, RF, Technology, Xfinity, Solution, Alexa, Control, Government, Automation, Google, Health, URC, Complete Control, Marketing, Medical device, Mobile phone, Product

HARRISON, N.Y. and LITTLETON, Mass., Nov. 10, 2022 /PRNewswire-PRWeb/ -- URC, a global leader in smart living automation and control for residential and commercial applications, and ZeeVee, a global manufacturer of video and signal distribution technology, announced today a collaboration making the companies' control platforms compatible to serve a wide range of AV applications.

Key Points: 
  • URC's Total Control, an award-winning residential and commercial automation platform, can now interface with ZeeVee's flagship ZyPer Management Platform via a new plug-in that will enable full control of ZeeVee ZyPer Series AVoIP encoders and decoders.
  • ZeeVee provides AVoIP and streaming products that deliver solutions to thousands of AV system deployments around the world.
  • URC control systems include Total Control and Complete Control.
  • URC systems are custom designed, installed and maintained by a network of URC trained systems integration professionals.

Instruqt Welcomes Alon Gildoni to Leadership Team as VP of Product

Retrieved on: 
Thursday, November 10, 2022
Cloud, Financial technology, Red Hat, Google Cloud, Learning, PLG, Adoption, Hebrew University of Jerusalem, HashiCorp, Booking.com, Mambu, Philosophy, MongoDB, Software as a service, SimilarWeb, Growth, CEO, VP, Alon, Datadog, Commercial, Management, Video game, Product

AMSTERDAM, The Netherlands, Nov. 10, 2022 /PRNewswire-PRWeb/ -- Instruqt, the #1 Hands-on Virtual IT Lab for product-led growth, has announced the appointment of Alon Gildoni as Vice President of Product. Gildoni brings an impressive track record of winning the market through customer centricity, innovation, and disruption. Alon will drive Instruqt's product strategy and work closely with the Product and Commercial teams to build the next generation of Instruqt's PLG offering.

Key Points: 
  • Instruqt expands the leadership team with VP of Product as the company accelerates investment in its product strategy and execution, further solidifying its position as the #1 hands-on virtual IT lab for product-led growth.
  • AMSTERDAM, The Netherlands, Nov. 10, 2022 /PRNewswire-PRWeb/ -- Instruqt , the #1 Hands-on Virtual IT Lab for product-led growth, has announced the appointment of Alon Gildoni as Vice President of Product.
  • Alon will drive Instruqt's product strategy and work closely with the Product and Commercial teams to build the next generation of Instruqt's PLG offering.
  • Alon's experience in leading product teams in high-growth organizations is a great asset for Instruqt," said Coert Baart , CEO at Instruqt.

"Click Chemistry" Concept Inspires BiOLinkMatrix by HALLURA™: the Next Generation of HA Dermal Fillers

Retrieved on: 
Thursday, November 10, 2022
Chemistry, Hyaluronic acid, Lego, Tissue engineering, IT University of Copenhagen, HA, Technology, Scripps Research, Nobel Prize in Chemistry, R, Product, Nobel Prize, Safety, Click chemistry, Stanford University, Copenhagen, Skin, Elasticity, University, CEO, Fine chemical, Paint

YOKNEAM, Israel, Nov. 10, 2022 /PRNewswire/ -- Hallura Ltd., an Israeli aesthetic medical company, announced today that its proprietary technology named the BiOLinkMatrix platform was inspired by the 2022 Nobel Prize for Click Chemistry. Harnessing this concept, Hallura's products revolutionize the way Hyaluronic Acid (HA) is cross-linked in dermal fillers for great elasticity and tolerance while being biodegradable and highly safe. 

Key Points: 
  • Harnessing this concept, Hallura's products revolutionize the way Hyaluronic Acid (HA) is cross-linked in dermal fillers for great elasticity and tolerancewhile being biodegradable and highly safe.
  • Hallura harnessed this advanced concept in its proprietary BiOLinkMatrix platform to revolutionize the way HA is crosslinked in Dermal Fillers.
  • Typical HA dermal fillers are cross-linked viathe chemical BDDE, or other epoxides, activated under harsh conditions with very little control over concurrent damage to the HA polymer.
  • Hallura's HA dermal fillers answer the growing demand for better, safer fillers with natural and soft aesthetic results.